Skip to Content

Allopurinol Pregnancy and Breastfeeding Warnings

Allopurinol is also known as: Aloprim, Lopurin, Zyloprim

Allopurinol Pregnancy Warnings

Allopurinol has been assigned to pregnancy category C by the FDA. Animal studies using high doses have revealed evidence of fetotoxicity and teratogenicity; it is not clear if these effects are a result of direct toxicity or maternal toxicity. There are no controlled data in human pregnancy. Allopurinol should only be given during pregnancy when benefit outweighs risk.

See references

Allopurinol Breastfeeding Warnings

Allopurinol and its active metabolite, oxypurinol, are excreted into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering allopurinol to nursing women. Allopurinol is considered compatible with breast-feeding by the American Academy of Pediatrics.

In a case study of a 5-week old infant, the excretion of allopurinol and oxypurinol into human milk was evaluated following maternal ingestion of allopurinol 300 mg once daily for 4 weeks. Milk allopurinol levels were 0.9 and 1.4 mcg/mL, with corresponding milk to plasma ratios of 0.9 and 1.4, at 2 and 4 hours post-dose, respectively. Milk oxypurinol levels were 53.7 and 48 mcg/mL, with corresponding milk to plasma ratios of 3.9 and 2.4, at 2 and 4 hours post-dose, respectively. Two hours after breast-feeding (4 hours post-dose), allopurinol levels were undetectable in the infant's serum while oxypurinol was present at a concentration of 6.6 mcg/mL. There was no evidence of side effects in the infant, including no changes in standard clinical chemistry and hematology, during 6 weeks of maternal allopurinol therapy and regular breast-feeding (150 mL/kg/day).

See references

References for pregnancy information

  1. "Product Information. Aloprim (allopurinol)." Nabi, Boca Raton, FL.
  2. "Product Information. Zyloprim capsules (allopurinol)." Glaxo Wellcome, Research Triangle Park, NC.

References for breastfeeding information

  1. Committee on Drugs, 1992 to 1993 "The transfer of drugs and other chemicals into human milk." Pediatrics 93 (1994): 137-50
  2. "Product Information. Zyloprim capsules (allopurinol)." Glaxo Wellcome, Research Triangle Park, NC.
  3. Kamilli I, Gresser U "Allopurinol and oxypurinol in human breast milk." Clin Investig 71 (1993): 161-4

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.